These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11475691)

  • 1. Bacteria are winning.
    Teuscher GW
    ASDC J Dent Child; 2001; 68(2):88. PubMed ID: 11475691
    [No Abstract]   [Full Text] [Related]  

  • 2. Enemy within. Basic weapons can foil VRE (vancomycin-resistant enterococcus).
    Pugliese G
    Mater Manag Health Care; 1997 Sep; 6(9):32, 34, 36-8. PubMed ID: 10173223
    [No Abstract]   [Full Text] [Related]  

  • 3. Tracking ties to infection. As rates of hospital-acquired infections have risen, adding billions in costs, experts view a wide range of remedies.
    Mantone J
    Mod Healthc; 2006 Jul; 36(29):30-1. PubMed ID: 16958381
    [No Abstract]   [Full Text] [Related]  

  • 4. Implementing guidelines for the control and prevention of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: how valid are international comparisons of success?
    Humphreys H
    J Hosp Infect; 2006 Feb; 62(2):133-5. PubMed ID: 16337032
    [No Abstract]   [Full Text] [Related]  

  • 5. [The Dutch MRSA policy should be retained].
    Vlaminckx BJ; Troelstra A; van der Bruggen T
    Ned Tijdschr Geneeskd; 2006 Aug; 150(34):1884. PubMed ID: 16970011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective digestive tract decontamination--will it prevent infection with multidrug-resistant gram-negative pathogens but still be applicable in institutions where methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci are endemic?
    Bonten MJ
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S70-4. PubMed ID: 16894518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital superbugs. Physician, wash thyself, and other medical safety tips.
    Watson T
    US News World Rep; 1997 Feb; 122(6):64-6. PubMed ID: 10165090
    [No Abstract]   [Full Text] [Related]  

  • 8. Hospital's aggressive screening efforts save money in long run.
    Health Care Cost Reengineering Rep; 1997 Sep; 2(9):135-40. PubMed ID: 10173922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging nosocomial infections and antimicrobial resistance.
    Gerberding JL; McGowan JE; Tenover FC
    Curr Clin Top Infect Dis; 1999; 19():83-98. PubMed ID: 10472481
    [No Abstract]   [Full Text] [Related]  

  • 10. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
    Nelson RR
    Lancet; 1997 Nov; 350(9087):1327. PubMed ID: 9357432
    [No Abstract]   [Full Text] [Related]  

  • 11. New strategies to identify patients harbouring antibiotic-resistant bacteria at hospital admission.
    Tacconelli E
    Clin Microbiol Infect; 2006 Feb; 12(2):102-9. PubMed ID: 16441446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin resistance in gram-positive cocci.
    Courvalin P
    Clin Infect Dis; 2006 Jan; 42 Suppl 1():S25-34. PubMed ID: 16323116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of daptomycin against isolates of Staphylococcus aureus and enterococci: first results from Turkey.
    Arslan H; Azap OK; Ergin F; Karaman SO; Oruç E
    Int J Antimicrob Agents; 2004 Jun; 23(6):642-3. PubMed ID: 15194140
    [No Abstract]   [Full Text] [Related]  

  • 14. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers.
    Mauldin PD; Salgado CD; Durkalski VL; Bosso JA
    Ann Pharmacother; 2008 Mar; 42(3):317-26. PubMed ID: 18285560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
    Florescu I; Beuran M; Dimov R; Razbadauskas A; Bochan M; Fichev G; Dukart G; Babinchak T; Cooper CA; Ellis-Grosse EJ; Dartois N; Gandjini H;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i17-28. PubMed ID: 18684703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multiresistant bacteria in dermatology].
    Lucet JC
    Ann Dermatol Venereol; 1998 Oct; 125(10):669-71. PubMed ID: 9835952
    [No Abstract]   [Full Text] [Related]  

  • 17. Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010.
    Nordmann P; Naas T; Fortineau N; Poirel L
    Curr Opin Microbiol; 2007 Oct; 10(5):436-40. PubMed ID: 17765004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of enteral vancomycin for the control of methicillin-resistant Staphylococcus aureus in intensive care units.
    Humphreys H; Smyth EG
    J Hosp Infect; 2005 Mar; 59(3):259-61; author reply 263-6. PubMed ID: 15694985
    [No Abstract]   [Full Text] [Related]  

  • 19. Update on emerging infections: news from the Centers for Disease Control and Prevention.
    Moran GJ; Mount J
    Ann Emerg Med; 2003 Jan; 41(1):148-51. PubMed ID: 12514697
    [No Abstract]   [Full Text] [Related]  

  • 20. A new class of anti-MRSA and anti-VRE agents: preparation and antibacterial activities of indole-containing compounds.
    Yamamoto Y; Kurazono M
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1626-8. PubMed ID: 17254785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.